AAAAAA
Results:
1-23
|
Results: 23
Authors:
Holm, G
Angelin, B
Fagrell, B
De Faire, U
Ljunghall, S
Citation: G. Holm et al., Renewal of the Journal, J INTERN M, 250(1), 2001, pp. 1-2
Authors:
Holm, G
Angelin, B
de Faire, U
Fagrell, B
Ljunghall, S
Citation: G. Holm et al., Journal of Internal Medicine and the new century, J INTERN M, 249, 2001, pp. 1-2
Authors:
Rudling, M
Angelin, B
Citation: M. Rudling et B. Angelin, Growth hormone reduces plasma cholesterol in LDL receptor-deficient mice, FASEB J, 15(8), 2001, pp. 1350-1356
Authors:
Alberti, S
Schuster, G
Parini, P
Feltkamp, D
Diczfalusy, U
Rudling, M
Angelin, B
Bjorkhem, I
Pettersson, S
Gustafsson, JA
Citation: S. Alberti et al., Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXR beta-deficient mice, J CLIN INV, 107(5), 2001, pp. 565-573
Authors:
Parini, P
Angelin, B
Stavreus-Evers, A
Freyschuss, B
Eriksson, H
Rudling, M
Citation: P. Parini et al., Biphasic effects of the natural estrogen 17 beta-estradiol on hepatic cholesterol metabolism in intact female rats, ART THROM V, 20(7), 2000, pp. 1817-1823
Authors:
Holm, G
Angelin, B
de Faire, U
Fagrell, B
Ljunghall, S
Citation: G. Holm et al., Journal of Internal Medicine and the new century, J INTERN M, 247(1), 2000, pp. 1-2
Authors:
Gullberg, H
Rudling, M
Forrest, D
Angelin, B
Vennstrom, B
Citation: H. Gullberg et al., Thyroid hormone receptor beta-deficient mice show complete loss of the normal cholesterol 7 alpha-hydroxylase (CYP7A) response to thyroid hormone butdisplay enhanced resistance to dietary cholesterol, MOL ENDOCR, 14(11), 2000, pp. 1739-1749
Authors:
Werynski, A
Nahorski, Z
Angelin, B
Berglund, L
Eriksson, M
Citation: A. Werynski et al., Kinetic analysis of LDL apoB transport and metabolism in non-steady states, CONTROL CYB, 29(1), 2000, pp. 405-425
Authors:
Liao, W
Rudling, M
Angelin, B
Citation: W. Liao et al., Insulin-like growth factor I for growth hormone therapy, LANCET, 355(9198), 2000, pp. 148-148
Authors:
Stenvinkel, P
Alvestrand, A
Angelin, B
Eriksson, M
Citation: P. Stenvinkel et al., LDL-apheresis in patients with nephrotic syndrome: effects on serum albumin and urinary albumin excretion, EUR J CL IN, 30(10), 2000, pp. 866-870
Authors:
Ohlsson, C
Hellberg, N
Parini, P
Vidal, O
Bohlooly, M
Rudling, M
Lindberg, MK
Warner, M
Angelin, B
Gustafsson, JA
Citation: C. Ohlsson et al., Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice, BIOC BIOP R, 278(3), 2000, pp. 640-645
Effects of growth hormone on hepatic cholesterol metabolism. Lessons from studies in rats and humans
Authors:
Rudling, M
Parini, P
Angelin, B
Citation: M. Rudling et al., Effects of growth hormone on hepatic cholesterol metabolism. Lessons from studies in rats and humans, GROWTH H I, 9, 1999, pp. 1-7
Authors:
Parini, P
Angelin, B
Rudling, M
Citation: P. Parini et al., Cholesterol and lipoprotein metabolism in aging - Reversal of hypercholesterolemia by growth hormone treatment in old rats, ART THROM V, 19(4), 1999, pp. 832-839
Authors:
Angelin, B
Eriksson, M
Rudling, M
Citation: B. Angelin et al., Bile acids and lipoprotein metabolism: a renaissance for bile acids in thepost-statin era?, CURR OP LIP, 10(3), 1999, pp. 269-274
Authors:
Hillebrant, CG
Nyberg, B
Angelin, B
Axelson, M
Bjorkhem, I
Rudling, M
Einarsson, C
Citation: Cg. Hillebrant et al., Deoxycholic acid treatment in patients with cholesterol gallstones: failure to detect a suppression of cholesterol 7 alpha-hydroxylase activity, J INTERN M, 246(4), 1999, pp. 399-407
Authors:
Liao, W
Rudling, M
Angelin, B
Citation: W. Liao et al., Endotoxin suppresses mouse hepatic low-density lipoprotein-receptor expression via a pathway independent of the Toll-like receptor 4, HEPATOLOGY, 30(5), 1999, pp. 1252-1256
Authors:
Berglund, L
Galbraith, RA
Emtestam, L
Drummond, GS
Angelin, B
Kappas, A
Citation: L. Berglund et al., Heme oxygenase inhibitors transiently increase serum ferritin concentrations without altering other acute-phase reactants in man, PHARMACOL, 59(1), 1999, pp. 51-56
Authors:
Nilsson, L
Gafvels, M
Musakka, L
Ensler, K
Strickland, DK
Angelin, B
Hamsten, A
Eriksson, P
Citation: L. Nilsson et al., VLDL activation of plasminogen activator inhibitor-1 (PAI-1) expression: involvement of the VLDL receptor, J LIPID RES, 40(5), 1999, pp. 913-919
Authors:
Olivecrona, H
Hilding, A
Ekstrom, C
Barle, H
Nyberg, B
Moller, C
Delhanty, PJ
Baxter, RC
Angelin, B
Ekstrom, TJ
Tally, M
Citation: H. Olivecrona et al., Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: Serum levels and hepatic messenger ribonucleic acid responses in humans, J CLIN END, 84(2), 1999, pp. 553-560
Authors:
Liao, W
Rudling, M
Moller, C
Angelin, B
Citation: W. Liao et al., Endogenous histamine reduces plasma insulin-like growth factor I via H-1 receptor-mediated pathway in the rat, EUR J PHARM, 374(3), 1999, pp. 471-476
Authors:
Werynski, A
Nahorski, Z
Berglund, L
Ericsson, S
Angelin, B
Eriksson, M
Citation: A. Werynski et al., Evidence of circadian rhythm in low-density lipoprotein apoB catabolism and its impact on the estimation of kinetic parameters, EUR J CL IN, 29(4), 1999, pp. 291-300
Authors:
Eriksson, M
Carlson, LA
Miettinen, TA
Angelin, B
Citation: M. Eriksson et al., Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I - Potential reverse cholesterol transport in humans, CIRCULATION, 100(6), 1999, pp. 594-598
Authors:
Rudling, M
Gafvels, M
Parini, P
Gahrton, G
Angelin, B
Citation: M. Rudling et al., Lipoprotein receptors in acute myelogenous leukemia - Failure to defect increased low-density lipoprotein (LDL) receptor numbers in cell membranes despite increased cellular LDL degradation, AM J PATH, 153(6), 1998, pp. 1923-1935
Risultati:
1-23
|